Jen-Fu Shih

784 citations
42 papers · 619 indexed · h-index 16
Topics
Lung Cancer Treatments and Mutations (29 papers)Lung Cancer Research Studies (20 papers)Lung Cancer Diagnosis and Treatment (16 papers)

In The Last Decade

Jen-Fu Shih

41 papers receiving 590 citations

Peers

Jen-Fu Shih
Comparison fields: 5 of 65
  • Pulmonary and Respiratory Medicine 422
  • Oncology 344
  • Infectious Diseases 113
  • Surgery 95
  • Epidemiology 86
Replace Osamu Kanai with:
Osamu Kanai Japan
Jacqueline Weinberg United States
Hiroko Tsukada Japan
Gökmen Umut Erdem Türkiye
Antonio Ponticiello Italy
Paolo Di Mattia Italy
Yunjoo Im South Korea
Mihailo Stjepanović Serbia
Sang Young Han South Korea
Angioletta Lasagna Italy
Jen-Fu Shih relative to Osamu Kanai Japan Osamu Kanai's profile →
Citations per field
00.5×10×15×21×
Osamu Kanai · 1×
Citations per year

Countries citing papers authored by Jen-Fu Shih

Since Specialization
Citations

This map shows the geographic impact of Jen-Fu Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen-Fu Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen-Fu Shih more than expected).

Fields of papers citing papers by Jen-Fu Shih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen-Fu Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen-Fu Shih. The network helps show where Jen-Fu Shih may publish in the future.

Co-authorship network of co-authors of Jen-Fu Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Jen-Fu Shih. A scholar is included among the top collaborators of Jen-Fu Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen-Fu Shih. Jen-Fu Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 10
3 7
4 23
5 51
6 16
7 16
8 1
9 0
10 17
11 12
12 20
13 12
14 80
15 12
16 10
17 16
18 40
19 4
20 25

About Jen-Fu Shih

Jen-Fu Shih is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases, having authored 42 papers that have together received 619 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (422 citations), Oncology (344 citations) and Infectious Diseases (113 citations). Jen-Fu Shih has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Reury-Perng Perng, Jacqueline Whang‐Peng, Yuh-Min Chen, Chun-Ming Tsai, Wei‐Juin Su, Yu-Chin Lee, Reury-Perng Perng, Chi‐Huei Chiang, Chieh-Hung Wu and Yuh‐Min Chen. Their work appears in journals such as Journal of Clinical Oncology, CHEST Journal and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026